Ralph V. Shohet to Endothelial Cells
This is a "connection" page, showing publications Ralph V. Shohet has written about Endothelial Cells.
Connection Strength
0.801
-
Walton CB, Shohet RV. Tiny bubbles and endocytosis? Circ Res. 2009 Mar 13; 104(5):563-5.
Score: 0.265
-
Cobb MS, Tao S, Shortt K, Girgis M, Hauptman J, Schriewer J, Chin Z, Dorfman E, Campbell K, Heruth DP, Shohet RV, Dawn B, Konorev EA. Smad3 promotes adverse cardiovascular remodeling and dysfunction in doxorubicin-treated hearts. Am J Physiol Heart Circ Physiol. 2022 12 01; 323(6):H1091-H1107.
Score: 0.170
-
Sun Z, Schriewer J, Tang M, Marlin J, Taylor F, Shohet RV, Konorev EA. The TGF-? pathway mediates doxorubicin effects on cardiac endothelial cells. J Mol Cell Cardiol. 2016 Jan; 90:129-38.
Score: 0.106
-
Darrow AL, Shohet RV. Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes. Cardiovasc Diabetol. 2015 Jun 06; 14:73.
Score: 0.102
-
Oladipupo S, Hu S, Kovalski J, Yao J, Santeford A, Sohn RE, Shohet R, Maslov K, Wang LV, Arbeit JM. VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting. Proc Natl Acad Sci U S A. 2011 Aug 09; 108(32):13264-9.
Score: 0.078
-
Maresh JG, Xu H, Jiang N, Shohet RV. In vivo transcriptional response of cardiac endothelium to lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2004 Oct; 24(10):1836-41.
Score: 0.048
-
Darrow AL, Shohet RV, Maresh JG. Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3. Physiol Genomics. 2011 Oct 20; 43(20):1144-52.
Score: 0.020
-
Korpanty G, Chen S, Shohet RV, Ding J, Yang B, Frenkel PA, Grayburn PA. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther. 2005 Sep; 12(17):1305-12.
Score: 0.013